Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages

Daniela Petrusca, Yuan Gu, Jeremy J. Adamowicz, Natalia I. Rush, Walter C. Hubbard, Patricia A. Smith, Evgeni V. Berdyshev, Konstantin G. Birukov, Chao-Hung Lee, Rubin M. Tuder, Homer Twigg, R. William Vandivier, Irina Petrache

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AMefferocytosis against the effects of ceramide. CS exposure significantly increasedAMceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibitedAM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.

Original languageEnglish
Pages (from-to)40322-40332
Number of pages11
JournalJournal of Biological Chemistry
Volume285
Issue number51
DOIs
StatePublished - Dec 17 2010

Fingerprint

Sphingolipids
Ceramides
Alveolar Macrophages
Cells
Sphingosine
Tobacco Products
Cytophagocytosis
Smoking
Emphysema
Inhibition (Psychology)
Lung
Rats
Ceramidases
Membranes
Alveolar Epithelial Cells
Sphingomyelin Phosphodiesterase
Jurkat Cells
Endothelial cells
Lung Injury
Thymocytes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages. / Petrusca, Daniela; Gu, Yuan; Adamowicz, Jeremy J.; Rush, Natalia I.; Hubbard, Walter C.; Smith, Patricia A.; Berdyshev, Evgeni V.; Birukov, Konstantin G.; Lee, Chao-Hung; Tuder, Rubin M.; Twigg, Homer; Vandivier, R. William; Petrache, Irina.

In: Journal of Biological Chemistry, Vol. 285, No. 51, 17.12.2010, p. 40322-40332.

Research output: Contribution to journalArticle

Petrusca, D, Gu, Y, Adamowicz, JJ, Rush, NI, Hubbard, WC, Smith, PA, Berdyshev, EV, Birukov, KG, Lee, C-H, Tuder, RM, Twigg, H, Vandivier, RW & Petrache, I 2010, 'Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages', Journal of Biological Chemistry, vol. 285, no. 51, pp. 40322-40332. https://doi.org/10.1074/jbc.M110.137604
Petrusca, Daniela ; Gu, Yuan ; Adamowicz, Jeremy J. ; Rush, Natalia I. ; Hubbard, Walter C. ; Smith, Patricia A. ; Berdyshev, Evgeni V. ; Birukov, Konstantin G. ; Lee, Chao-Hung ; Tuder, Rubin M. ; Twigg, Homer ; Vandivier, R. William ; Petrache, Irina. / Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 51. pp. 40322-40332.
@article{99b03deb5f30492890ad00730e57cc47,
title = "Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages",
abstract = "A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AMefferocytosis against the effects of ceramide. CS exposure significantly increasedAMceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibitedAM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.",
author = "Daniela Petrusca and Yuan Gu and Adamowicz, {Jeremy J.} and Rush, {Natalia I.} and Hubbard, {Walter C.} and Smith, {Patricia A.} and Berdyshev, {Evgeni V.} and Birukov, {Konstantin G.} and Chao-Hung Lee and Tuder, {Rubin M.} and Homer Twigg and Vandivier, {R. William} and Irina Petrache",
year = "2010",
month = "12",
day = "17",
doi = "10.1074/jbc.M110.137604",
language = "English",
volume = "285",
pages = "40322--40332",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages

AU - Petrusca, Daniela

AU - Gu, Yuan

AU - Adamowicz, Jeremy J.

AU - Rush, Natalia I.

AU - Hubbard, Walter C.

AU - Smith, Patricia A.

AU - Berdyshev, Evgeni V.

AU - Birukov, Konstantin G.

AU - Lee, Chao-Hung

AU - Tuder, Rubin M.

AU - Twigg, Homer

AU - Vandivier, R. William

AU - Petrache, Irina

PY - 2010/12/17

Y1 - 2010/12/17

N2 - A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AMefferocytosis against the effects of ceramide. CS exposure significantly increasedAMceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibitedAM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.

AB - A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AMefferocytosis against the effects of ceramide. CS exposure significantly increasedAMceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibitedAM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.

UR - http://www.scopus.com/inward/record.url?scp=78650057959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650057959&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.137604

DO - 10.1074/jbc.M110.137604

M3 - Article

VL - 285

SP - 40322

EP - 40332

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -